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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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Deciphering signals from Huntington’s disease
brains in the search for treatments
From coast to coast and around the world, scientists like Andrew F.
Leuchter, M.D., and Michael Levine, Ph.D., are engaged in the quest for
Huntington’s disease treatments.
During May, Huntington’s Disease Awareness Month, I want to call
attention to the critical work of Drs. Leuchter and Levine on the West
Coast. They exemplify the partnership of scientists and physicians with the
HD community, aiming to advance potential remedies into crucial clinical
trials.
Drs. Leuchter and Levine, faculty researchers at the renowned Semel
Institute for Neuroscience and Behavior at the University of California, Los
Angeles (UCLA), are collaborating on a project that could ultimately lead
to new drugs. In the near term, they aim to understand more fully the
electrical signals that naturally but abnormally emanate from the brains of
HD patients and presymptomatic carriers of the HD gene mutation like
me.
“Most of the brain’s energy goes to creating electrical gradients – electrical
impulses – but we haven’t been very good at using that for diagnosis and
treatment,” Dr. Leuchter said during a March 20 interview in his office at
the Semel Institute. He and Dr. Levine aim to “decipher the signals that
are coming out of the brain.”
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The Semel Institute for Neuroscience and Behavior (photo by Gene
Veritas)
Measuring brain energy
A psychiatrist specializing in depression and Alzheimer’s disease, Dr.
Leuchter (pronounced LUKE-ter) frequently employs quantitative
electroencephalography (quantitative EEG) to measure the energy
emitting from people’s brains. One example: a group of 27 HD subjects he
and others observed for a study published in 2010 and funded by CHDI
Foundation, Inc., the nonprofit virtual biotech dedicated exclusively to the
discovery of HD treatments.
Allan Tobin, Ph.D., at the time the head of UCLA’s Brain Research
Institute and a senior scientific advisor at CHDI, had asked colleague
Leuchter for assistance in finding HD biomarkers, signals that reveal the
progression of the disease and/or the effectiveness of a medication.
As the number of HD clinical trials expands exponentially, the search for
useful biomarkers has become one of the hottest areas in Huntington's
disease research. (Click here to read about one new potential biomarker.)
As Dr. Leuchter pointed out, neurological and psychiatric disorders are
“much more limited in diagnostic tests for the organ that we are studying
than any other branch of medicine.” Cardiologists insert catheters into the
heart, and gastroenterologists use scopes to view the stomach and
intestines.
“If you’re a psychiatrist, we talk to people, which is great, but we don’t have
physiologic tests that guide decision-making,” he added.
Scientists and doctors rarely put electrodes in living human brains or take
biopsies of brain tissue. However, they have been measuring brain energy
with EEGs for more than a century, Dr. Leuchter explained.
As he demonstrated in his lab (see photo below), today patients
undergoing testing wear a cap with 35 separate EEG electrodes, or
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contacts, that touch the head. The attending researcher stretches the cap
over the patient’s head. In contrast with the traditional EEG, which
involves one-by-one placement of the electrodes on the head, this method
is quick, efficient, and less burdensome to patients, he noted.

Above, Dr. Andrew Leuchter points out the electrodes on the EEG cap
worn by research subjects. Below, he explains digitized EEG readings
displayed on a computer monitor. (photos by Gene Veritas)

“We find that this helps to standardize our measurements of brain activity,
and that we can place the electrodes in about 15 minutes,” Dr. Leuchter
said.
EEG is inexpensive, convenient, and easy to administer. Additionally, it
does not expose patients to radiation or require them to lie inside a
machine such as an MRI scanner, he noted.
“You can tote it wherever you like,” he said of the EEG device.
The brain’s pacemaker
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As they had hoped, Dr. Leuchter and three other UCLA researchers
discovered abnormal EEG readings in HD patients with just mild
symptoms.
“But the really intriguing thing there was that, even in people who were
gene-positive but premanifest, we could see differences in brain function
estimated 15, 20 years out from diagnosis,” Dr. Leuchter said, referring to
signals of future decline. “So we thought this could be something that
could be useful for treatment development.”
As Dr. Leuchter explained, “the brain like the heart has pacemakers.”
Healthy brains produce lots of high-frequency waves. Brain illnesses
commonly result from changes in the firing of the pacemaker, resulting in
a greater quantity of low-frequency waves.
“What we found is that years before people start to show symptoms with
Huntington’s, they’re producing more low-wave energy,” Dr. Leuchter
said. “So it’s a very subtle indicator that the pacemaker of the brain is
starting to slow down.”
Scientists cannot predict the actual onset and progression of symptoms
from EEG signals. However, as noted below, they did discover a
correlation between the severity of genetic mutation and EEG readings.
Clear genetic impact on the brain
Furthermore, the team observed that, in contrast with healthy brains, the
distribution of different types of waves across the different regions of the
HD brains became more uniform. “The regions of the brain start to look
more similar than different,” he explained.
Researchers have not yet discovered what this phenomenon means.
“We know that the brain has enormous functional reserve and that people
call on every cognitive and emotional resource they’ve got to try to keep
everything functioning at optimal efficiency,” Dr. Leuchter continued. “I
don’t think we know what’s compensatory and what’s an early sign of
illness.”
Reflecting on another facet of the research, Dr. Leuchter explained that, in
general, brain function tests do not correlate with genetic factors.
However, he and his team did find a correlation between the degree of HD
genetic mutation and the severity of the changes in the EEG readings.
“Nobody had seen that,” he recalled. “We got excited about that, and that’s
what we’ve been trying to follow up on.” These findings will contribute to
the search for biomarkers and treatments, as explained below.
Examining brain tissue
A neurophysiologist and veteran basal ganglia researcher, since the late
1960s Dr. Levine has studied these deep, inner parts of the brain that
control such actions as voluntary movements. He began to study HD in the
1990s as genetic mouse models with HD-like symptoms became available.
His lab has published more than two dozen papers about these mice.
The nuclei of the basal ganglia are significantly compromised in HD,
especially in the striatum. Specifically, Dr. Levine has examined how
neurons communicate with each other in the cortex and striatum at
cellular and molecular levels using tissue from the HD mouse models.
One of the latest techniques for studying the cells in the HD mouse models
is optogenetics, in which specific types of brain cells are stimulated with
light.
curehd.blogspot.com/2015/05/deciphering-signals-from-huntingtons.html
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“I can look very closely at mechanisms,” Dr. Levine explained. “I know
which types of neurons I am looking at and how they change at a very
mechanistic level.”

Michael Levine, Ph.D., veteran HD researcher (photo by Gene Veritas)
Two key goals
Melding approaches, and with the expectation of CHDI support, Drs.
Leuchter and Levine now seek to answer two important questions.
The first involves comparing EEG data from both mice and humans to
refine the search for biomarkers. Researchers have already made the key
discovery of EEG signals common to mice and humans.
“It’s actually pretty uncommon in science that you can see a very similar
signal across species, that you can see something very similar in the brains
of humans and the brains of animals,” Dr. Leuchter said.
If the Leuchter-Levine project confirms the degree of that similarity, that
could mean potential drugs tested in mice could ultimately be used for
human clinical trials, Dr. Leuchter observed.
The second question focuses on the testing in HD mice of a CHDIdeveloped compound aimed at lowering the amount of mutant huntingtin
protein, the major culprit in the disease.
“If we do see a link between lowering of mutant huntingtin and change in
the EEG biomarker, this could be used to develop a number of therapeutic
agents,” Dr. Leuchter said. “A whole line of research could develop out of
this.”
From molecule to the whole brain
Drs. Leuchter and Levine estimated the project will take two years to
complete.
curehd.blogspot.com/2015/05/deciphering-signals-from-huntingtons.html
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As Dr. Levine put it, researchers hope the CHDI-developed compound will
restore the EEG signals in HD patients to normal.
Dr. Leuchter reflected on the significance of the project and his
collaboration with Dr. Levine: “The fact that in something like
Huntington’s disease you’ve got a protein that is affecting how the nerve
cells are functioning and altering the way they produce and utilize energy
– it’s really a gateway to understanding the connection between what is
going on at the deepest molecular level of the cell and what we’re able to
see with the brain waves the individual is putting out. We can actually
potentially link everything going from the level of the gene all the way to
whole-brain function.”
In another potential future project, Dr. Leuchter would like to obtain EEG
readings from asymptomatic gene carriers over two to three years to better
measure the changes in signals over time.

Drs. Leuchter and Levine (photo by Gene Veritas)
Participation and a positive attitude
Both researchers expressed gratitude to the HD community and fellow HD
researchers for their dedication to the cause.
“There are not that many people with this illness, so people get asked a lot
to participate in different studies where they’re poked or prodded or
scanned,” Dr. Leuchter said. “We are very grateful to those who are so
generous with their time, because without their help we could not conduct
these research studies.”
Dr. Levine added that he is impressed with the “very positive and sharing
attitude of the investigators who do research in HD and who are looking to
help the patients.”
While interviewing these two researchers, as an individual racing against
the genetic clock of HD, I was once again moved to witness the creativity
and enthusiasm of scientists engaged in the quest to save affected families
from the devastation of Huntington’s.
(Later this month: from the East Coast a report on Yale School of
Medicine researcher Doug Rothman, Ph.D., and the mystery of the
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mitochondria in Huntington’s disease. Please remember during HD
Awareness Month to donate generously to the Huntington’s Disease
Society of America or the HD cause of your choice!)
Posted by Gene Veritas at 4:30 PM
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Unknown said...
I am praying for these doctor's success.
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